Rcm Technologies, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
RCM Technologies, Inc. has filed an amendment to its 2025 Form 10-K, primarily to include Part III disclosures previously intended for incorporation by reference.
NASDAQ
RCM Technologies Inc. announced a 14.7% increase in revenue for fiscal year 2025, driven by growth in its Specialty Health Care and Engineering segments.
NASDAQ
RCM Technologies files an amendment to its annual report to include information previously intended to be incorporated by reference from the company's proxy statement.
NASDAQ
RCM Technologies files an amended 10-K to correct an error in the independent accounting firm's report, clarifying that the company maintained effective internal control over financial reporting as of December 28, 2024.
NASDAQ
RCM Technologies, Inc. reports a 5.8% increase in revenue for fiscal year 2024, driven by growth in Specialty Health Care and Engineering segments, while navigating economic uncertainties and strategic initiatives.
NASDAQ
RCM Technologies has filed an amendment to its annual report on Form 10-K to include information previously intended to be incorporated by reference from its proxy statement.
NASDAQ
RCM Technologies' annual 10-K filing reveals a decrease in revenue, ongoing internal control issues, and details of its financial performance for the fiscal year ended December 30, 2023.